This can be of interest, given the ongoing development of therapeutic interventions in the cranio-cervical region.
Such advances in antibody technologies have resulted in an explosion in the development of therapeutic mAbs over the last decade.
Understanding molecular regulation of cell junctions is important for development of therapeutic strategies for intervention of human diseases.
The antiglobulin response is perceived as a major problem in the clinical development of therapeutic antibodies.
Therefore, there is an acute need for the development of therapeutic vaccines for HPV associated cancers.
Despite these impediments, there is progress in the design and development of therapeutic agents.
The development of therapeutic antibodies has grown over the last several years.
Our study provides insights into the development of therapeutic drugs for type 2 diabetes.
Therefore, the continued development of therapeutic and prophylactic countermeasures to potentially deadly coronaviruses is warranted.
Refining such knowledge will permit the development of therapeutic treatments against MMSCs, including immunotherapy.
Therefore, development of therapeutic strategies or agents targeting HIV-infected macrophage is urgently needed.
